July 9, 2020 Japan – Davis Polk Advises Sumitomo Mitsui Financial Group On Its $3 Billion SEC-Registered Notes Offering.
July 9, 2020 Hong Kong – Davis Polk Advises Shenzhen Hepalink Pharmaceutical Group Co., Ltd. On Its HK$4.05 Billion ($523 Million) Initial Public Offering.
